The medtech industry is expected to grow at 5.6% per year (CAGR) between 2017-2024, report finds
A report by EvaluateMedTech has found that the global medtech industry is expected to grow at close to 6% per year (CAGR) between 2017-2014, with global sales forecast to reach $595bn by 2024.
Medtronic will retain its position as the leading company by medical device revenue, with sales of close to $39bn. The company will also continue to spend the most on research and development, with expenditure forecast to reach $2.7bn in 2024, which is closely followed by the cardiology market, with sales of $14.2bn and a forecast of $73bn in sales by 2024.
Although in vitro diagnostics is forecasted to remain the largest area in medtech in 2024 with sales of up to $80bn, neurology is set to become the fastest growing device area, with a CAGR of 9.1% between 2017-2014.
Despite this, Medtronic is facing stiff competition from competitors. Johnson & Johnson is presently the company’s main competitor, gaining $26.6bn in sales in 2017. The following companies also made the list for worldwide medical sales for 2017-2024.
See also
- Virtual female health clinic Maven secures $27mn in funding
- CVS Health is set to build healthier communities in Ohio
- Medtronic is set to acquire Mazor Robotics for $1.6bn
- Abbott Laboratories
- Siemens Healthineers
- Becton Dickinson
- Philips
- Stryker
- Roche
- Boston Scientific
- General Electric
- Essilor International
- Danaher
- B. Braun Melsungen
- Baxter International
- Zimmer Biomet
- Novartis
- Olympus
- 3M
- Terumo
- Edwards Lifesciences
Research and development spend will continue to rise as the number of complex long-term conditions, amidst an ageing global population continues to reshape traditional models of care. Becton Dickinson and Edwards Lifesciences have been forecasted to increased their annual spend the most int his area, growing at a CAGR of 8.4% and 8.3% respectively, according to the report.
Additionally, Siemens Healthineers will remain a leader in diagnostic imaging, followed by Philips and General Electric.
- 'Can't Just Throw AI at Medical Devices' - MedTech ExpertMedical Devices & Pharma
- Abbott Labs' profits soar; Nipro opens First US FacilityMedical Devices & Pharma
- Signia’s Brian Taylor on audiology & medical devicesMedical Devices & Pharma
- Top 10 European healthcare companiesMedical Devices & Pharma
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency